CollinsS, MazloomzadehS, WinterH, et al.High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG, 2002; 109(1):96–98.
2.
https://www.cdc.gov/std/hpv/stdfact-hpv.htm. Cervical cancer screening; 2022.
3.
SchiffmanM, CastlePE, JeronimoJ, et al.Human papillomavirus and cervical cancer. Lancet, 2007; 370(9590):890–907.
4.
uspreventiveservicestaskforce.org. Cervical cancer screening; 2018.
5.
FonthamETH, WolfAMD, ChurchTR, et al.Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin, 2020; 70(5):321–346.
6.
CuschieriK, BhatiaR, CruickshankM, et al.HPV testing in the context of post-treatment follow up (test of cure). J Clin Virol, 2016; 76(Suppl. 1):S56–S61.
7.
SavilleM, SultanaF, MalloyMJ, et al.Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol, 2019; 57(2); doi: 10.1128/JCM.01239-18.
8.
CastlePE, BurkRD, MassadLS, et al.Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study. Int J Cancer, 2020; 146(12):3320–3328.
9.
HammerA, de KoningMN, BlaakaerJ, et al.Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans. Papillomavirus Res, 2019; 7:82–87.
10.
SpeckSH, GanemD. Viral latency and its regulation: Lessons from the gamma-herpesviruses. Cell Host Microbe, 2010; 8(1):100–115.
11.
DenisF, HanzS, AlainS. [Clearance, persistence and recurrence of HPV infection]. Gynecol Obstet Fertil, 2008; 36(4):430–440.
12.
ZhouC, TuongZK, FrazerIH. Papillomavirus immune evasion strategies target the infected cell and the local immune system. Front Oncol, 2019; 9:682.
13.
MaglennonGA, McIntoshPB, DoorbarJ. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J Virol, 2014; 88(1):710–716.
14.
ZhangJ, LiuG, CuiX, et al.Human papillomavirus genotypes and the risk factors associated with multicentric intraepithelial lesions of the lower genital tract: A retrospective study. BMC Infect Dis, 2021; 21(1):554.
15.
EleuterioJJr., CavalcanteLR, GoncalvesAKS, et al.Prevalence of high-risk HPV and atypia in liquid-based cytology of cervical and intra-anal specimens from kidney-transplanted women. Diagn Cytopathol, 2019; 47(8):783–787.
16.
PaulP, HammerA, RositchAF, et al.Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. J Infect Dis, 2021; 223(8):1423–1432.
